Pfizer Would Reap Huge Tax Savings in AstraZeneca Deal

Tuesday, 29 April 2014 | by Pat's Picks

Pfizer has many reasons for wanting to acquire British rival AstraZeneca for $100 billion. The Wall Street Journal says one of the less obvious reasons is the to save billions of dollars in taxes. Pfizer would likely move its U.S. headquarters overseas - to pay a tax rate. Pfizer would move largely in name only, keeping its operational headquarters in New York.

SOURCE: Wall Street Journal